Biotech Values

[willyw]

The virus keeps shape shifting.

Omicron ba.5 is more infectious.

It's hard to know yet about how serious this is, but the notion of long covid, or the cumulative effect of multiple infections is concerning.

If we are seeing a lag in coverage in vaccines, or fewer people getting boosted, fewer precautions it seems likely that with more infections will come a need for a good antiviral.

Enanta may have a superior antiviral to Paxlovid, and it would appear that the need for one is going to increase. Fauci himself, had a case of what was called "Paxlovid rebound".

https://www.msn.com/en-us/sports/more-sports/covid-ucsf-expert-calls-ba5-variant-a-beast-with-a-new-superpower/vi-AAZeWXc